Evidence map›Paper›PMID 35863744›Full record

ArticleCellular and molecular gastroenterology and hepatology2022

Undifferentiated Induced Pluripotent Stem Cells as a Genetic Model for Nonalcoholic Fatty Liver Disease.

Antonio Muñoz, Elizabeth Theusch, Yu-Lin Kuang, Gilbert Nalula, Caitlin Peaslee, Gabriel Dorlhiac, Markita P Landry, Aaron Streets, Ronald M Krauss, Carlos Iribarren and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cellular and molecular gastroenterology and hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Antonio MuñozDepartment of Pediatrics, University of California San Francisco, San Francisco, California.
Elizabeth TheuschDepartment of Pediatrics, University of California San Francisco, San Francisco, California.
Yu-Lin KuangDepartment of Pediatrics, University of California San Francisco, San Francisco, California.
Gilbert NalulaDepartment of Pediatrics, University of California San Francisco, San Francisco, California.
Caitlin PeasleeDepartment of Pathology, University of California San Francisco, San Francisco, California.
Gabriel DorlhiacBiophysics Graduate Group, University of California Berkeley, Berkeley, California.
Markita P LandryDepartment of Chemical and Biomolecular Engineering, University of California Berkeley, Berkeley, California; Chan Zuckerberg Biohub, San Francisco, California.
Aaron StreetsBiophysics Graduate Group, University of California Berkeley, Berkeley, California; Chan Zuckerberg Biohub, San Francisco, California; Department of Bioengineering, University of California Berkeley, Berkeley, California.
Ronald M KraussDepartment of Pediatrics, University of California San Francisco, San Francisco, California; Department of Medicine, University of California San Francisco, San Francisco, California.
Carlos IribarrenKaiser Permanente Division of Research, Oakland, California.
Aras N MattisDepartment of Pathology, University of California San Francisco, San Francisco, California; Liver Center, University of California San Francisco, San Francisco, California. Electronic address: aras.mattis@ucsf.edu.
Marisa W MedinaDepartment of Pediatrics, University of California San Francisco, San Francisco, California. Electronic address: marisa.medina@ucsf.edu.

Funding

UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jennifer Y. Chen · 1986 to 2026
$30.7M
Pharmacogenomics of Statin TherapyP50GM115318 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RISCH, NEIL J. · 2015 to 2019
$14.0M
MOLECULAR BIOPHYSICS TRAINING GRANTT32GM008295 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI HURLEY, JAMES H, WEMMER, DAVID E · 1989 to 2022
$8.1M
Systems Genetics Dissection of Non-alcoholic SteatohepatitisR01DK117850 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Aldons Jake Lusis · 2019 to 2026
$4.6M
Genetic Regulation of Nonalcoholic Fatty Liver DiseaseR01DK130391 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTIS, ARAS NIKODEMAS, MEDINA, MARISA WONG · 2021 to 2024
$2.2M
NIDDK NIH HHS P30 DK026743NIDDK NIH HHS R01 DK117850NIDDK NIH HHS R01 DK130391NIGMS NIH HHS P50 GM115318NIGMS NIH HHS T32 GM008295
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Induced Pluripotent Stem CellsNon-alcoholic Fatty Liver DiseasePluripotent Stem CellsCell DifferentiationHumansModels, Genetic

Identifiers

PMID35863744
PMCPMC9608362

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.